ICLUSIG cpr pell 30 mg bte 30 pce
7680630970060
CH-63097
L01EA05
07.16.1.
Reimbursement limitations:
ICLUSIG
ICLUSIG est remboursé chez les patients adultes atteints de
- Leucémie myéloïde chronique à …
1 / 3
google
Details
- Product number
- 6309703
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- ponatinibum 30 mg ut ponatinibi hydrochloridum, lactosum monohydricum 80.30 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.352 mg, silica colloidalis anhydrica, magnesii stearas, pellicule: talcum, macrogolum 4000, poly(alcohol vinylicus), E 171, pro compresso obducto.
Articles (1)
Iclusig 30 mg, comprimés pelliculés
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
80.3 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.352 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 4918.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2023
Authorization holder
Incyte Biosciences International
1110 Morges
Authorization information
- Swissmedic authorization number
- 63097
- Drug name
- Iclusig, comprimés pelliculés
- Galenic form
- FILM
- ATC Code
- L01EA05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 12/02/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ICLUSIG cpr pell 30 mg bte 30 pce
- Description (DE)
- ICLUSIG Filmtabl 30 mg Ds 30 Stk
- Market launch
- 01/09/2016
- Narcotic (BTM)
- No